Dettmer MS - Search Results

1

BRAF^V600E Overrides NOTCH Signaling in Thyroid Cancer.

Traversi F, Stooss A, Dettmer MS, Charles RP. Traversi F, et al. Among authors: dettmer ms. Thyroid. 2021 May;31(5):787-799. doi: 10.1089/thy.2019.0595. Epub 2020 Nov 12. Thyroid. 2021. PMID: 33012268

2

Comprehensive MicroRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma.

Dettmer M, Perren A, Moch H, Komminoth P, Nikiforov YE, Nikiforova MN. Dettmer M, et al. Thyroid. 2013 Nov;23(11):1383-9. doi: 10.1089/thy.2012.0632. Epub 2013 Sep 19. Thyroid. 2013. PMID: 23427895 Free PMC article.

3

Combined MEK and Pi3'-kinase inhibition reveals synergy in targeting thyroid cancer in vitro and in vivo.

ElMokh O, Ruffieux-Daidié D, Roelli MA, Stooss A, Phillips WA, Gertsch J, Dettmer MS, Charles RP. ElMokh O, et al. Among authors: dettmer ms. Oncotarget. 2017 Apr 11;8(15):24604-24620. doi: 10.18632/oncotarget.15599. Oncotarget. 2017. PMID: 28445948 Free PMC article.

4

PIK3CA^H1047R-induced paradoxical ERK activation results in resistance to BRAF^V600E specific inhibitors in BRAF^V600E PIK3CA^H1047R double mutant thyroid tumors.

Roelli MA, Ruffieux-Daidié D, Stooss A, ElMokh O, Phillips WA, Dettmer MS, Charles RP. Roelli MA, et al. Among authors: dettmer ms. Oncotarget. 2017 Oct 11;8(61):103207-103222. doi: 10.18632/oncotarget.21732. eCollection 2017 Nov 28. Oncotarget. 2017. PMID: 29262556 Free PMC article.

5

The LAT1 inhibitor JPH203 reduces growth of thyroid carcinoma in a fully immunocompetent mouse model.

Häfliger P, Graff J, Rubin M, Stooss A, Dettmer MS, Altmann KH, Gertsch J, Charles RP. Häfliger P, et al. Among authors: dettmer ms. J Exp Clin Cancer Res. 2018 Sep 21;37(1):234. doi: 10.1186/s13046-018-0907-z. J Exp Clin Cancer Res. 2018. PMID: 30241549 Free PMC article.

6

MEK Inhibition Induces Therapeutic Iodine Uptake in a Murine Model of Anaplastic Thyroid Cancer.

ElMokh O, Taelman V, Radojewski P, Roelli MA, Stoss A, Dumont RA, Dettmer MS, Phillips WA, Walter MA, Charles RP. ElMokh O, et al. Among authors: dettmer ms. J Nucl Med. 2019 Jul;60(7):917-923. doi: 10.2967/jnumed.118.216721. Epub 2018 Nov 21. J Nucl Med. 2019. PMID: 30464041 Free article.

7

Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy.

Schürch CM, Roelli MA, Forster S, Wasmer MH, Brühl F, Maire RS, Di Pancrazio S, Ruepp MD, Giger R, Perren A, Schmitt AM, Krebs P, Charles RP, Dettmer MS. Schürch CM, et al. Among authors: dettmer ms. Thyroid. 2019 Jul;29(7):979-992. doi: 10.1089/thy.2018.0555. Epub 2019 May 10. Thyroid. 2019. PMID: 30938231 Free PMC article.

8

Tall cell papillary thyroid carcinoma: new diagnostic criteria and mutations in BRAF and TERT.

Dettmer MS, Schmitt A, Steinert H, Capper D, Moch H, Komminoth P, Perren A. Dettmer MS, et al. Endocr Relat Cancer. 2015 Jun;22(3):419-29. doi: 10.1530/ERC-15-0057. Epub 2015 Apr 13. Endocr Relat Cancer. 2015. PMID: 25870252 Free article.

9

Poorly differentiated thyroid carcinoma : An underdiagnosed entity.

Dettmer MS, Schmitt A, Komminoth P, Perren A. Dettmer MS, et al. Pathologe. 2020 Jun;41(Suppl 1):1-8. doi: 10.1007/s00292-019-0600-9. Pathologe. 2020. PMID: 31273418 Free PMC article. Review.

10

Poorly differentiated thyroid carcinomas: how much poorly differentiated is needed?

Dettmer M, Schmitt A, Steinert H, Haldemann A, Meili A, Moch H, Komminoth P, Perren A. Dettmer M, et al. Am J Surg Pathol. 2011 Dec;35(12):1866-72. doi: 10.1097/PAS.0b013e31822cf962. Am J Surg Pathol. 2011. PMID: 21989341

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters